Antony, France

François Rebiere


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: François Rebiere: Innovator in Pharmaceutical and Cosmetic Formulations

Introduction

François Rebiere is a notable inventor based in Antony, France. He has made significant contributions to the fields of pharmaceuticals and cosmetics, holding a total of four patents. His innovative work focuses on the application of calixarene molecules and the synthesis of enantiomers.

Latest Patents

One of François Rebiere's latest patents is titled "Cosmetic and pharmaceutical formulations of calixarene molecules." This invention relates to the use of calixarenes for preventing or limiting the transfer of actinides in the body from a site of skin contamination. Another significant patent is the "Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation." This invention describes a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form.

Career Highlights

Throughout his career, François Rebiere has worked with prominent organizations such as Cephalon France and the Institut de Radioprotection et de Sureté Nucléaire. His work in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical and cosmetic sectors.

Collaborations

François has collaborated with notable professionals in his field, including Gérard Duret and Laurence Prat. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

François Rebiere is a distinguished inventor whose work in pharmaceutical and cosmetic formulations has made a significant impact. His innovative patents and collaborations highlight his dedication to advancing science and technology in these fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…